- Professor emeritus named world expert in type 2 diabetes mellitus
- Professor Cliff Bailey contributed to the development of metformin the most widely prescribed drug for type 2 diabetes
- Professor Bailey and colleagues have also been involved in the development of a new class of medicines to treat type 2 diabetes called SGLT2 inhibitors
Aston University professor emeritus, Cliff Bailey has been named as a world expert in type 2 diabetes mellitus by Expertscape, based on his research publications over the last ten years.
Expertscape is designed to help find the most knowledgeable physicians and health professionals in the world. It objectively ranks people and institutions by their expertise in more than 27,000 biomedical topics.
The announcement coincides with World Diabetes Day on 14 November – which marks the birthday of Frederick Banting, one of the discoverers of insulin.
Cliff Bailey, professor of clinical science, and his colleagues in the College of Health and Life Sciences contributed key information to the development of metformin, now the most prescribed medicine in the world for the treatment of type 2 diabetes which is also on the World Health Organisation’s (WHO) list of essential medicines.
More recently Cliff has been involved in the development of a new class of agents called SGLT2 inhibitors which are being used alongside metformin in the treatment of type 2 diabetes.
Professor Cliff Bailey said: “I’m really pleased that our work continues to help people with diabetes to control their blood glucose and stay healthy.”
Cliff has received several awards including the Banting Memorial Lecture Award – the highest award of Diabetes UK - and the Outstanding Achievement Award of the Lunar Society.
Type 2 diabetes is the most common type of diabetes that affects more than 400 million people worldwide, including over four million people in the UK. It usually develops in middle or later life, is characterised by excess glucose in the blood, and usually results from a combination of impaired production and impaired activity of the hormone insulin.
Type 2 diabetes has extensive detrimental effects on the heart, blood vessels, kidneys, eyes and nerves, and accounts for about 10% of the NHS budget.
For more information about studying subjects in the College of Health and Life Sciences such as biomedical sciences, medicine, pharmacy and ophthalmology please visit our website.
- Notes to editors
Cliff Bailey is a Professor of Clinical Science and holds an Anniversary Chair at Aston University where he has been Head of Diabetes Research and Director of Biomedical Research.
About Aston University
Founded in 1895 and a University since 1966, Aston is a long established university led by its three main beneficiaries – students, business and the professions, and our region and society. Aston University is located in Birmingham and at the heart of a vibrant city and the campus houses all the university’s academic, social and accommodation facilities for our students. Professor Alec Cameron is the Vice-Chancellor & Chief Executive.
Aston University was named University of the Year 2020 by The Guardian and the University’s full time MBA programme has been ranked in the top 100 in the world in the Economist MBA 2021 ranking. The Aston MBA has been ranked 12th in the UK and 85th in the world.
For media inquiries in relation to this release, contact Rebecca Hume, Press and Communications Manager, on (+44)7557 745416 or email: r.hume@aston.ac.uk
Be first to get the latest news, research and expert comment from Aston by following us on Twitter
Need an expert for your story? Browse our expert directory